Periodontal Therapeutics Market Size
The global periodontal therapeutics market reached US$ 1,005.93 million in 2024 and is expected to reach US$ 1,950.35 million by 2033, growing at a CAGR of 7.2 % during the forecast period of 2025-2033.
The global periodontal therapeutics market encompasses a range of products and treatments specifically designed to manage periodontal diseases, which are infections that affect the supporting structures of the teeth, including the gums, periodontal ligament, and alveolar bone. These diseases primarily manifest as gingivitis and periodontitis, both of which can lead to significant oral health complications if not addressed.
Gingivitis is a common and mild form of gum disease characterized by inflammation of the gums. It often presents as redness, swelling, and bleeding, particularly during brushing or flossing. On the other hand, periodontitis is a more severe form of gum disease that develops when gingivitis is left untreated.
Executive Summary
For more details on this report, Request for Sample
Periodontal Therapeutics Market Dynamics
Rising Prevalence of Periodontal Diseases
The rising prevalence of periodontal diseases is a significant driver in the global periodontal therapeutics market. Periodontal diseases, which include a variety of inflammatory conditions that impact the supporting structures of the teeth, have seen a notable increase in prevalence worldwide.
Factors such as increasing awareness of oral health, a growing geriatric population, and advancements in dental technology are driving the expansion of the periodontal therapeutics market. Furthermore, key players in the industry are implementing strategies such as partnerships and collaborations that would drive this market growth. For instance, in May 2023, OraPharma announced a strategic partnership with Alex Rodriguez, a renowned sports figure and health advocate, to enhance awareness about the importance of managing gum disease. This collaboration is part of the Cover Your Bases campaign, which aims to educate the public, particularly within the Hispanic community, about the prevalence and implications of gum disease.
Lack of Awareness among People
The lack of awareness and education regarding periodontal diseases significantly constrains the global periodontal therapeutics market. Despite some progress in raising awareness about oral health, many individuals remain uninformed about the signs, symptoms, and consequences of periodontal diseases.
Research indicates that a substantial portion of the population lacks basic knowledge about the etiology of these conditions, which can lead to delayed diagnosis and treatment. For instance, a systematic review highlighted that poor awareness is frequently cited as a primary reason for treatment failure within communities.
The lack of awareness directly affects individuals' willingness to seek treatment. Many people may underestimate the importance of regular dental check-ups or fail to recognize early signs of gum disease, leading to a higher prevalence of untreated conditions. For instance, a study found that low awareness was associated with fewer perceived periodontal health issues, and that individuals might not prioritize dental visits if they do not understand the risks involved.
Periodontal Therapeutics Market Segment Analysis
The global periodontal therapeutics market is segmented based on disease type, drug type, route of administration, and region.
Disease Type:
The gingivitis segment in disease type is expected to dominate the global periodontal therapeutics market with the highest market share
Gingivitis, the mildest form of periodontal disease, is primarily caused by plaque accumulation on the teeth and gums, leading to inflammation, redness, swelling, and occasional bleeding. While generally reversible with professional treatment and good oral hygiene, untreated gingivitis can progress to periodontitis, making early intervention critical.
The rising awareness of oral health, growing emphasis on preventive care, and the increasing availability of over-the-counter and prescription therapeutics are driving demand in this segment. Topical antimicrobials, antiseptic mouth rinses, and enzyme suppressants are commonly used to treat gingivitis, and their market demand is supported by continuous product innovation.
Additionally, public health campaigns, dental screening programs, and school-based oral care initiatives further contribute to the segment’s growth by promoting early diagnosis and treatment. As oral hygiene becomes more closely associated with overall systemic health, the gingivitis segment is expected to expand steadily, particularly in emerging markets where improvements in dental care infrastructure are underway. These factors have solidified the segment's position in the global periodontal therapeutics market.
Periodontal Therapeutics Market Geographical Share
North America is expected to hold a significant position in the global periodontal therapeutics market with the highest market share
​The region’s dominance is largely attributed to the high prevalence of periodontal diseases, especially among the aging population, and the widespread adoption of advanced therapeutic solutions. According to the CDC, nearly half of adults over 30 in the U.S. suffer from some form of periodontal disease, creating a substantial demand for effective treatment modalities.
A substantial portion of the adult population in North America is affected by periodontal diseases. In the United States, approximately 42% of adults aged 30 years and older suffer from periodontitis, highlighting a significant demand for effective therapeutic interventions. ​
The region's aging demographic is more susceptible to periodontal conditions due to factors like systemic health issues and decreased immunity. As people retain their natural teeth longer, the need for periodontal care increases, driving the market for therapeutics that address these age-related oral health challenges.​
Innovations in dental technology have introduced advanced treatment options such as local drug delivery systems, laser therapies, and regenerative techniques. These advancements offer more effective, less invasive, and patient-friendly solutions, enhancing treatment outcomes and patient compliance. ​
North America hosts several leading pharmaceutical and dental companies actively involved in the development and distribution of periodontal therapeutics. Collaborations between research institutions and industry players have led to significant investments in clinical trials and product development, fostering innovation and market growth.
Periodontal Therapeutics Market Major Players
The major global players in the periodontal therapeutics market include Pfizer Inc., Lupin, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Limited, Cipla, Advacare, Bausch Health Companies Inc., US Antibiotics, and Melinta Therapeutics, among others.
Key Developments
- In April 2025, ​Convergent Dental introduced the Solea Perioguide, a next-generation laser application designed for minimally invasive periodontal therapy. Building upon the capabilities of its predecessor, Ultraguide, this innovation enables dentists to perform in-pocket laser treatments for moderate to severe periodontitis with enhanced precision and patient comfort.
- In May 2023, OraPharma announced a strategic partnership with Alex Rodriguez, a renowned sports figure and health advocate, to enhance awareness about the importance of managing gum disease. This collaboration is part of the Cover Your Bases campaign, which aims to educate the public, particularly within the Hispanic community, about the prevalence and implications of gum disease.
| Metrics | Details | |
| CAGR | 7.2% | |
| Market Size Available for Years | 2022-2033 | |
| Estimation Forecast Period | 2025-2033 | |
| Revenue Units | Value (US$ Mn) | |
| Segments Covered | Disease Type | Gingivitis, Chronic Periodontitis, Aggressive Periodontitis, Others |
| Drug Type | Doxycycline, Minocycline, Metronidazole, Rapamycin, Chlorhexidine, Others | |
| Route of Administration | Oral, Parenteral | |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and the Middle East & Africa | |
Why Purchase the Report?
- Pipeline & Innovations: Reviews ongoing clinical trials and product pipelines and forecasts upcoming advancements in medical devices and pharmaceuticals.
- Product Performance & Market Positioning: Analyzed product performance, market positioning, and growth potential to optimize strategies.
- Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
- Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
- Market Updates & Industry Changes: This covers recent regulatory changes, new policies, and emerging technologies.
- Competitive Strategies: Analyze competitor strategies, market share, and emerging players.
- Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
- Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
- Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
- Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
- Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
- Post-market Surveillance: Uses post-market data to enhance product safety and access.
- Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.
The global periodontal therapeutics market report delivers a detailed analysis with 59 key tables, more than 54 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.
Target Audience 2024
- Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
- Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
- Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
- Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
- Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
- Supply Chain: Distribution and Supply Chain Managers.
- Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
- Academic & Research: Academic Institutions.
